Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carboxylesterase 5A (CES5A) is an enzyme from the carboxylesterase superfamily that catalyzes the hydrolysis or transesterification of a wide variety of esters, including drugs, xenobiotics, and endogenous lipid substrates[1][3]. CES5A is encoded by the CES5A gene on human chromosome 16 and is structurally similar to other carboxylesterases but is distinguished by its secretion into body fluids such as urine and male reproductive fluids, and by several isoforms resulting from alternative splicing[1][3]. Its physiological roles include detoxification of foreign compounds, regulation of pheromonal activity (notably in some non-human mammals), lipid metabolism, and possibly neuroprotection from xenobiotics[1]. Unlike more widely studied family members CES1 and CES2, CES5A’s detailed substrate specificity and involvement in clinically significant drug metabolism are still being investigated.
Catalyzes hydrolysis and transesterification of carboxylesters, thioesters, and aromatic amides Detoxifies and metabolizes some xenobiotics (including certain narcotics and clinical drugs) May activate or inactivate prodrugs as part of drug metabolism pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carboxylesterase 5A (CES5A).